|
| 37410376 | Knowledge, attitudes and practices regarding the use of mobile travel health apps. | J Travel Med | 2024 |
| 36268576 | Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study. | Clin Infect Dis | 2023 |
| 37668364 | Coding-complete genomes of XBB.1.16, XBB.2.3, FL.4 (alias of XBB.1.9.1.4), and XBB.3 of SARS-CoV-2 Omicron isolated from Bangladesh. | Microbiol Resour Announc | 2023 |
| 37783453 | Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1. | Am J Trop Med Hyg | 2023 |
| 37646517 | Comparison of O-specific polysaccharide responses in patients following infection with <i>Vibrio cholerae</i> O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh. | mSphere | 2023 |
| 37392327 | Mass photometry: A powerful tool for carbohydrates-proteins conjugation monitoring and glycoconjugates molecular mass determination. | Glycoconj J | 2023 |
| 37022168 | Intrinsic Resistance to Colistin in the Genus <i>Hafnia</i>. | J Clin Microbiol | 2023 |
| 37205407 | Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden setting. | bioRxiv | 2023 |
| 37400283 | Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry. | Vaccine | 2023 |
| 36907197 | Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study. | Lancet Microbe | 2023 |
| 36864572 | Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers. | J Travel Med | 2023 |
| 35904457 | Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions. | J Travel Med | 2023 |
| 35170309 | Virus-like Particle Display of <i>Vibrio cholerae</i><i>O</i>-Specific Polysaccharide as a Potential Vaccine against Cholera. | ACS Infect Dis | 2022 |
| 35587156 | Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19. | Virulence | 2022 |
| 35721426 | Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection. | IJID Reg | 2022 |
| 35720155 | Covishield vaccine induces robust immune responses in Bangladeshi adults. | IJID Reg | 2022 |
| 35750069 | Estimating typhoid incidence from community-based serosurveys: a multicohort study. | Lancet Microbe | 2022 |
| 35551522 | Mucosal-Associated Invariant T (MAIT) cells are highly activated in duodenal tissue of humans with Vibrio cholerae O1 infection: A preliminary report. | PLoS Negl Trop Dis | 2022 |
| 36618409 | Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh. | Front Immunol | 2022 |
| 36578502 | Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh. | Front Immunol | 2022 |
| 36147447 | Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 Vaccination. | Pathog Immun | 2022 |
| 36072570 | Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of <i>Vibrio cholerae</i> O1 Vaccination. | Pathog Immun | 2022 |
| 36000001 | High-risk US International Travelers Seeking Pretravel Consultation During the COVID-19 Pandemic. | Open Forum Infect Dis | 2022 |
| 36173766 | Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022. | MMWR Recomm Rep | 2022 |
| 35864532 | Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19. | Cardiovasc Diabetol | 2022 |
| 36169311 | Vibrio cholerae Isolation from Frozen Vomitus and Stool Samples. | J Clin Microbiol | 2022 |
| 36286520 | Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay. | mBio | 2022 |
| 35977496 | Systems approach to define humoral correlates of immunity to Shigella. | Cell Rep | 2022 |
| 34982773 | Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh. | PLoS Negl Trop Dis | 2022 |
| 34855508 | Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. | Science | 2022 |
| 35311584 | The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients. | Microbiol Spectr | 2022 |
| 35333347 | The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad. | J Pediatric Infect Dis Soc | 2022 |
| 34875080 | Evaluation of Candida auris acquisition in US international travellers using a culture-based screening protocol1. | J Travel Med | 2022 |
| 32610345 | Predicting Vibrio cholerae Infection and Disease Severity Using Metagenomics in a Prospective Cohort Study. | J Infect Dis | 2021 |
| 33910997 | Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera. | mSphere | 2021 |
| 33879588 | Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of <i>Vibrio cholerae</i> O-Specific Polysaccharide-Specific Monoclonal Antibodies. | mBio | 2021 |
| 33872211 | Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine. | Am J Trop Med Hyg | 2021 |
| 33564833 | Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator). | Clin Infect Dis | 2021 |
| 33589825 | Humoral signatures of protective and pathological SARS-CoV-2 infection in children. | Nat Med | 2021 |
| 33534766 | Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018. | Am J Trop Med Hyg | 2021 |
| 33886672 | An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh. | PLoS One | 2021 |
| 34758256 | Case 34-2021: A 38-Year-Old Man with Altered Mental Status and New Onset of Seizures. | N Engl J Med | 2021 |
| 34427503 | A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients. | mSystems | 2021 |
| 34842841 | Systemic, Mucosal, and Memory Immune Responses following Cholera. | Trop Med Infect Dis | 2021 |
| 34716040 | Scalable production and immunogenicity of a cholera conjugate vaccine. | Vaccine | 2021 |
| 34232076 | Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139. | mSphere | 2021 |
| 34228490 | Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine. | Infect Immun | 2021 |
| 34049977 | Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay. | J Clin Pathol | 2021 |
| 34280200 | Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. | PLoS Negl Trop Dis | 2021 |
| 33303686 | Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. | Science | 2021 |